Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?

Robert C Brasch; Axel Gossmann; Thomas H Helbich; Nagato Kuriyama; Timothy P L Roberts; David M Shames; N van Bruggen; Michael F Wendland; Mark A Israel

doi:10.1016/s1076-6332(03)80218-0

Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?

Identifier:nobleid.org/w1/20260515/89DB35AF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/89DB35AF.svg?ark=w1%2F20260515%2F89DB35AF)](https://nobleid.org/work/w1/20260515/89DB35AF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?

Identifier:nobleid.org/w1/20260515/89DB35AF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/89DB35AF.svg?ark=w1%2F20260515%2F89DB35AF)](https://nobleid.org/work/w1/20260515/89DB35AF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work